Edition:
United States

Edwards Lifesciences Corp (EW)

EW on New York Consolidated

113.56USD
23 May 2017
Change (% chg)

$-0.53 (-0.46%)
Prev Close
$114.09
Open
$114.00
Day's High
$114.23
Day's Low
$113.43
Volume
296,414
Avg. Vol
2,067,410
52-wk High
$121.75
52-wk Low
$81.12

EW

Chart for EW

About

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan... (more)

Overall

Beta: 0.67
Market Cap(Mil.): $23,082.63
Shares Outstanding(Mil.): 211.19
Dividend: --
Yield (%): --

Financials

  EW Industry Sector
P/E (TTM): 36.17 51.87 30.38
EPS (TTM): 3.02 -- --
ROI: 17.30 6.82 13.36
ROE: 26.05 10.82 14.50

BRIEF-Edwards Lifesciences Q1 earnings per share $1.06

* Says Q1 earnings per share $1.06; Q1 adjusted earnings per share $0.94; Q1 sales grew 27 percent to $884 million

Apr 25 2017

Edwards profit tops expectations on soaring heart valve sales

Edwards Lifesciences Corp on Tuesday reported higher-than expected first-quarter profit and revenue on surging sales of transcatheter heart valve replacements and raised its full-year earnings forecast to reflect the strong start to the year.

Apr 25 2017

UPDATE 1-Edwards profit tops expectations on soaring heart valve sales

April 25 Edwards Lifesciences Corp on Tuesday reported higher-than expected first-quarter profit and revenue on surging sales of transcatheter heart valve replacements and raised its full-year earnings forecast to reflect the strong start to the year.

Apr 25 2017

Edwards profit tops expectations on soaring heart valve sales

April 25 Edwards Lifesciences Corp on Tuesday reported higher-than expected first-quarter profit and revenue on surging sales of transcatheter heart valve replacements, and raised its full-year earnings forecast to reflect the strong start to the year.

Apr 25 2017

BRIEF-German patent court issues initial decision

* District court in Germany ruled that Boston Scientific's lotus valve infringes one of co's patents for transcatheter aortic valves

Mar 09 2017

BRIEF-Boston Scientific receives favorable rulings in Edwards Lifesciences litigation

* Boston scientific receives favorable rulings in edwards lifesciences litigation

Mar 09 2017

Edwards Lifesciences fourth-quarter sales, profit top expectations

Edwards Lifesciences Corp on Wednesday reported higher-than-expected fourth-quarter profit and revenue on surging demand for its minimally invasive heart valve replacement systems.

Feb 01 2017

Edwards Lifesciences 4th-quarter sales, profit top expectations

Feb 1 Edwards Lifesciences Corp on Wednesday reported higher-than-expected fourth-quarter profit and revenue on surging demand for its minimally invasive heart valve replacement systems.

Feb 01 2017

BRIEF-Edwards Lifesciences Corp Q4 EPS $0.73

* Q4 global transcatheter heart valve therapy sales up 29 percent to $432 million

Feb 01 2017

Edwards wins more than $20 million in interest in heart valve dispute

A federal judge in Boston awarded Edwards Lifesciences Corp $20.7 million in prejudgment interest on top of the $91 million it already won in a trade secret lawsuit against rival Neovasc Inc, bringing the total to more than $111 million.

Jan 19 2017

More From Around the Web

Earnings vs. Estimates